Literature DB >> 27439966

L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.

Yu Zhang1, Long-Jian Huang1, Si Shi1, Shao-Feng Xu1, Xiao-Liang Wang1, Ying Peng1.   

Abstract

AIMS: Our previous studies showed that L-3-n-butylphthalide (L-NBP), an extract from seeds of Apium graveolens Linn (Chinese celery), improved cognitive ability in animal models of cerebral ischemia, vascular dementia, and Alzheimer's disease (AD). It is well known that cognitive deficit of AD is caused by synaptic dysfunction. In this study, we investigated the effect of L-NBP on hippocampal synaptic function in APP/PS1 AD transgenic mice and related mechanisms.
METHODS: Eighteen-month-old APP/PS1 transgenic (Tg) mice were administrated 15 mg/kg L-NBP by oral gavage for 3 months. Synaptic morphology and the thickness of postsynaptic density (PSD) in hippocampal neurons were investigated by electron microscope. The dendritic spines, Aβ plaques, and glial activation were detected by staining. The expressions of synapse-related proteins were observed by Western blotting.
RESULTS: L-NBP treatment significantly increased the number of synapses and apical dendritic thorns and the thickness of PSD, increased the expression levels of synapse-associated proteins including PSD95, synaptophysin (SYN), β-catenin, and GSK-3β, and attenuated Aβ plaques and neuroinflammatory responses in aged APP/PS1 Tg mice.
CONCLUSION: L-NBP may restore synaptic and spine function in aged APP Tg mice through inhibiting Aβ plaques deposition and neuroinflammatory response. Wnt/β-catenin signaling pathway may be involved in L-NBP-related restoration of synaptic function.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Aβ; Golgi staining; L-3-n-butylphthalide; Mitochondrial function; Synaptic plasticity

Mesh:

Substances:

Year:  2016        PMID: 27439966      PMCID: PMC6492814          DOI: 10.1111/cns.12594

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  56 in total

1.  Co-expression of multiple transgenes in mouse CNS: a comparison of strategies.

Authors:  J L Jankowsky; H H Slunt; T Ratovitski; N A Jenkins; N G Copeland; D R Borchelt
Journal:  Biomol Eng       Date:  2001-06

2.  Estrogen, progestogen and tamoxifen increase synaptic density of the hippocampus of ovariectomized rats.

Authors:  I Silva; L E Mello; E Freymüller; M A Haidar; E C Baracat
Journal:  Neurosci Lett       Date:  2000-09-22       Impact factor: 3.046

Review 3.  Dendritic spine pathology: cause or consequence of neurological disorders?

Authors:  John C Fiala; Josef Spacek; Kristen M Harris
Journal:  Brain Res Brain Res Rev       Date:  2002-06

Review 4.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

Review 5.  Structure-stability-function relationships of dendritic spines.

Authors:  Haruo Kasai; Masanori Matsuzaki; Jun Noguchi; Nobuaki Yasumatsu; Hiroyuki Nakahara
Journal:  Trends Neurosci       Date:  2003-07       Impact factor: 13.837

Review 6.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

7.  Synaptic alterations in the vestibulocerebellar system in Alzheimer's disease--a Golgi and electron microscope study.

Authors:  S J Baloyannis; S L Manolidis; L S Manolidis
Journal:  Acta Otolaryngol       Date:  2000-03       Impact factor: 1.494

8.  Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells.

Authors:  M H Orme; A L Giannini; M D Vivanco; R M Kypta
Journal:  Mol Cell Neurosci       Date:  2003-11       Impact factor: 4.314

Review 9.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  Beta-catenin is critical for dendritic morphogenesis.

Authors:  Xiang Yu; Robert C Malenka
Journal:  Nat Neurosci       Date:  2003-10-05       Impact factor: 24.884

View more
  21 in total

1.  Dl-3-n-butylphthalide Attenuates Spinal Cord Injury via Regulation of MMPs and Junction Proteins in Mice.

Authors:  Binbin Zheng; Yanjun Jin; Shuang Mi; Wei Xu; Xiangdong Yang; Zhenghua Hong; Zhangfu Wang
Journal:  Neurochem Res       Date:  2021-06-04       Impact factor: 3.996

2.  Dl-3-n-Butylphthalide improves lipopolysaccharide-induced depressive-like behavior in rats: involvement of Nrf2 and NF-κB pathways.

Authors:  Mengqi Yang; Ruili Dang; Pengfei Xu; Yujin Guo; Wenxiu Han; Dehua Liao; Pei Jiang
Journal:  Psychopharmacology (Berl)       Date:  2018-06-25       Impact factor: 4.530

3.  [Protective effect of butylphthalide in a cell model of Alzheimer's disease induced by Aβ25-35 in Neuro 2a cells].

Authors:  Jing-Wen Xie; Yan Zhao; Xia-Lu Feng; Fang-Bo Lin; Jing Luo; Xin Liu; De-Ren Hou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

Review 4.  Interaction of NF-κB and Wnt/β-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments.

Authors:  Xiao Liu; Kaiyue Wang; Xing Wei; Tian Xie; Bin Lv; Qian Zhou; Xiaoying Wang
Journal:  Neurochem Res       Date:  2021-02-01       Impact factor: 3.996

5.  Butylphthalide soft capsules combined with modified tonic exercise therapy on neurological function and ability of daily living of patients with stroke hemiplegia.

Authors:  You Lv; Qingxiu Zhang; Liangqun Rong; Xiu'e Wei; Haiyan Liu; Zhining Li
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

6.  CaMKIIα Signaling Is Required for the Neuroprotective Effects of Dl-3-n-Butylphthalide in Alzheimer's Disease.

Authors:  Bing-Qiu Li; Ling-Zhi Xu; Fang-Yu Li; Ying Li; Yu Zhao; Heng Zhang; Mei-Na Quan; Jian-Ping Jia
Journal:  Mol Neurobiol       Date:  2022-03-19       Impact factor: 5.590

7.  L-3-n-Butylphthalide improves synaptic and dendritic spine plasticity and ameliorates neurite pathology in Alzheimer's disease mouse model and cultured hippocampal neurons.

Authors:  Longjian Huang; Jiaqi Lan; Jingshu Tang; Yuying Kang; Xinhong Feng; Lei Wu; Ying Peng
Journal:  Mol Neurobiol       Date:  2020-11-03       Impact factor: 5.590

Review 8.  A Review of Recent Advances in Neuroprotective Potential of 3-N-Butylphthalide and Its Derivatives.

Authors:  Idriss Ali Abdoulaye; Yi Jing Guo
Journal:  Biomed Res Int       Date:  2016-12-08       Impact factor: 3.411

9.  Commentary: L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.

Authors:  Prakash C Bhatt; Preeti Pandey; Bibhu P Panda; Firoz Anwar; Vikas Kumar
Journal:  Front Aging Neurosci       Date:  2017-01-26       Impact factor: 5.750

10.  DL0410 ameliorates cognitive disorder in SAMP8 mice by promoting mitochondrial dynamics and the NMDAR-CREB-BDNF pathway.

Authors:  Wen-Wen Lian; Wei Zhou; Bao-Yue Zhang; Hao Jia; Lv-Jie Xu; Ai-Lin Liu; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2020-08-31       Impact factor: 7.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.